§ 07 · ABOUT
About GHK-Cu DR
GHK-Cu is a small protein part that holds copper. This page explains what we cover, what we don't do, and what that means for you.
What GHK-Cu DR tells you
Three tiny parts used to build protein make up GHK-Cu and hold its copper. We explain what studies found about the compound. The papers start with a 1973 report and end with 2024 work on scars and skin. Each finding tells you whether the test used people, animals, tissue, or cells.
What GHK-Cu DR can't do for your care
No clinic or medical staff runs this site. We don't give medical advice, set a dose, make products, or sell them. The letters “DR” don't mean that a doctor works here. They are part of the name, not a claim about your care.
What the numbered paper links mean for you
A number beside a claim leads to the matching paper in study references. One research team wrote much of the early GHK-Cu work. Other teams later checked skin, wounds, hair roots, and lungs. When the groups agree, that adds support, though it still doesn't replace a large human trial.
What each group of GHK-Cu studies tested
The list starts with the 1973 report. A 1994 study tested diabetic sores, and a 2002 study tested face cream. Studies from 2006 and 2007 covered laser aftercare and hair-root cells.
A 2012 paper tested damaged lung cells. Work from 2015 and 2018 looked at cell damage and repair. A 2022 mouse study and two 2024 papers close the list. Together, these studies offer clues, not settled care for you.
What GHK-Cu product rules mean for you
A clinician can prescribe compounded GHK-Cu for injection after an individual review, but that product has no FDA approval. Skin products may call it Copper Tripeptide-1. GHK-Cu is still sold in vials marked “research chemical”; those vials are for laboratory work, not human use.
Human proof is strongest for products spread on skin. Claims about shots or effects throughout the body rely on thin human work. We don't know how people handle GHK-Cu shots over time. That gap matters for your safety.